2011
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Abstract: The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3). Both joint and meta-analysis analysis approaches were used. We obtained genome-wide significant results at MS4A4A [rs4938933; Stages 1+2, meta-analysis (PM) = 1.7 × 10−9, joint analysis (PJ) = 1.7 × 10−9; Stages 1–3, PM = 8.2 × 10−12], CD2AP (rs9349407; Stages 1–3, PM…
Search citation statements
Paper Sections
Select...
1,482
413
200
128
Citation Types
47
1,690
12
8
Year Published
Range
2008
2027
Publication Types
Select...
1,630
188
168
102
Relationship
203
1,885
Authors
Journals
Cited by 2,083 publications
(1,757 citation statements)
References 40 publications
47
1,690
12
8
Smart CitationsHow the paper below cites the one you are viewing
“…Two associations near APOE , rs2075650 ( P = 2.05 × 10 −5 ) and rs4420638 ( P = 2.58 × 10 −6 ), surpassed this predefined P value threshold (eTable 1 in the Supplement). While the other tested GWAS variants were not significantly associated with AD, the overall direction of the association was highly consistent with previously reported results, 3–5 and 23 of 32 SNPs for which the risk allele was unambiguous showed the same direction of effect as previously reported ( P = .010, binomial test).…”
Section: Results
supporting
confidence: 91%